1. Home
  2. SAVA vs BIYA Comparison

SAVA vs BIYA Comparison

Compare SAVA & BIYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SAVA
  • BIYA
  • Stock Information
  • Founded
  • SAVA 1998
  • BIYA 2017
  • Country
  • SAVA United States
  • BIYA China
  • Employees
  • SAVA N/A
  • BIYA N/A
  • Industry
  • SAVA Biotechnology: Pharmaceutical Preparations
  • BIYA
  • Sector
  • SAVA Health Care
  • BIYA
  • Exchange
  • SAVA Nasdaq
  • BIYA NYSE
  • Market Cap
  • SAVA 70.5M
  • BIYA 61.6M
  • IPO Year
  • SAVA N/A
  • BIYA 2025
  • Fundamental
  • Price
  • SAVA $2.05
  • BIYA $0.85
  • Analyst Decision
  • SAVA Buy
  • BIYA
  • Analyst Count
  • SAVA 3
  • BIYA 0
  • Target Price
  • SAVA $54.50
  • BIYA N/A
  • AVG Volume (30 Days)
  • SAVA 1.2M
  • BIYA 737.3K
  • Earning Date
  • SAVA 08-07-2025
  • BIYA 05-13-2025
  • Dividend Yield
  • SAVA N/A
  • BIYA N/A
  • EPS Growth
  • SAVA N/A
  • BIYA N/A
  • EPS
  • SAVA N/A
  • BIYA N/A
  • Revenue
  • SAVA N/A
  • BIYA $12,809,211.00
  • Revenue This Year
  • SAVA N/A
  • BIYA N/A
  • Revenue Next Year
  • SAVA N/A
  • BIYA N/A
  • P/E Ratio
  • SAVA N/A
  • BIYA N/A
  • Revenue Growth
  • SAVA N/A
  • BIYA 10.66
  • 52 Week Low
  • SAVA $1.15
  • BIYA $0.83
  • 52 Week High
  • SAVA $42.20
  • BIYA $8.00
  • Technical
  • Relative Strength Index (RSI)
  • SAVA 51.70
  • BIYA N/A
  • Support Level
  • SAVA $2.02
  • BIYA N/A
  • Resistance Level
  • SAVA $2.25
  • BIYA N/A
  • Average True Range (ATR)
  • SAVA 0.11
  • BIYA 0.00
  • MACD
  • SAVA -0.02
  • BIYA 0.00
  • Stochastic Oscillator
  • SAVA 29.03
  • BIYA 0.00

About SAVA Cassava Sciences Inc.

Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. It is currently conducting two randomized placebo-controlled Phase 3 clinical trials of oral simufilam in patients with Alzheimer's disease dementia. It has one business segment: the development of novel drugs and diagnostics.

About BIYA BAIYA INTERNATIONAL GROUP INC

Baiya International Group Inc is a company which operates through its subsidiary Gongwuyuan operates a cloud-based internet platform to provide one-stop crowdsourcing recruitment and SaaS-enabled HR solutions in the flexible employment marketplace. The Company's business is focused around on four primary services which are job matching services, entrusted recruitment services, project outsourcing services and abor dispatching services in the flexible employment market within China, mainly in the core manufacturing regions including the Pearl River Delta and Yangtze River Delta region.

Share on Social Networks: